Cancer

February 5, 2015

Women’s basketball game to raise awareness of breast cancer

The stands inside Memorial Gymnasium are expected to resemble a sea of pink as fans don pink attire for the Vanderbilt Commodores Women’s Basketball game Sunday, Feb. 8, at noon.

By VUMC News and Communications
January 29, 2015

New therapy options enhance prostate cancer treatment

Vanderbilt-Ingram Cancer Center (VICC) patient William Ostman smiled while gazing into a camera lens and declared, “I am a prostate cancer survivor.”

By VUMC News and Communications
January 29, 2015

Grant bolsters pancreatic cancer drug discovery efforts

The Lustgarten Foundation has awarded a $1.5 million Research Investigator Grant to Stephen Fesik, Ph.D., professor of Biochemistry, Pharmacology and Chemistry, for research designed to discover new drugs for the treatment of pancreatic cancer.

By VUMC News and Communications
January 8, 2015

Study tracks combination therapy to treat melanoma

Melanoma is the most lethal form of skin cancer, with high mortality rates. While new drugs have been approved to treat the disease, patients nearly always develop resistance to the therapies and the cancer advances.

By VUMC News and Communications
January 8, 2015

Enzyme affects tumor metastasis

A protein that degrades the “matrix” between cells participates in the development of lung metastases from primary breast cancer in mouse models and may be a good target for breast cancer treatment.

By Daren Diiorio
January 5, 2015

Vanderbilt-led team studies blood test for prostate cancer

Vanderbilt University researcher William Mitchell, M.D., Ph.D., and colleagues in Germany and Canada have demonstrated a method for detecting “cell-free” tumor DNA in the bloodstream.

By Bill Snyder
November 21, 2014

Host sequesters zinc to control stomach bug

Understanding how zinc and the host’s immune response control H. pylori’s cancer-causing potential could suggest new therapeutic strategies to reduce infection and cancer risk.
By Leigh MacMillan
November 20, 2014

Gene mutation linked to breast cancer therapy resistance

A group of Vanderbilt-led investigators has identified a new gene mutation that may explain why some breast cancer patients do not respond to anti-hormone therapy.
By VUMC News and Communications
November 20, 2014

Tindle to direct Tobacco Research and Treatment

November is well-known as Lung Cancer Awareness Month. It is also the month that highlights awareness of less publicized forms of cancer including pancreatic cancer and stomach cancer.
By VUMC News and Communications
November 19, 2014

More breast cancer patients opting for mastectomy, Vanderbilt study finds

By VUMC News and Communications
November 12, 2014

New insight on oral cancer culprits

A new mouse model offers insight into the signaling pathways that control oral cancers – and a platform for testing anticancer therapeutics.
By Elizabeth Conrad
November 6, 2014

Immune cell activity and melanoma

The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells.
By VUMC News and Communications
October 30, 2014

Potential therapy for postpartum breast cancer investigated

Nearly 25 percent of all breast cancers among premenopausal women occur within two to five years following a pregnancy.
By VUMC News and Communications